The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2,6-dioxopiperidin-3-yl)-4-((2-((6-methoxy-4-(((R)-1-(3-(trifluoromethyl)phenyl)ethyl)amino)quinazolin-7-yl)oxy)ethyl)amino)isoindoline-1,3-dione ID: ALA5283419
Max Phase: Preclinical
Molecular Formula: C33H29F3N6O6
Molecular Weight: 662.63
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc2c(N[C@H](C)c3cccc(C(F)(F)F)c3)ncnc2cc1OCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C33H29F3N6O6/c1-17(18-5-3-6-19(13-18)33(34,35)36)40-29-21-14-25(47-2)26(15-23(21)38-16-39-29)48-12-11-37-22-8-4-7-20-28(22)32(46)42(31(20)45)24-9-10-27(43)41-30(24)44/h3-8,13-17,24,37H,9-12H2,1-2H3,(H,38,39,40)(H,41,43,44)/t17-,24?/m1/s1
Standard InChI Key: SYLBANHMIMFDAU-BPNWFJGMSA-N
Molfile:
RDKit 2D
48 53 0 0 0 0 0 0 0 0999 V2000
2.1836 -0.6238 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7532 -1.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5398 -1.1393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8924 -1.8987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6791 -2.0615 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2686 -2.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5633 -2.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8580 -2.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8580 -3.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5633 -3.6619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2686 -3.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1528 -2.0343 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4475 -2.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2577 -2.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9629 -2.4413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.6682 -2.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3734 -2.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0787 -2.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7839 -2.4413 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4621 -2.0343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4621 -1.2206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.7839 -0.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0787 -1.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3734 -0.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6682 -1.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9629 -0.8137 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2577 -1.2206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7839 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4621 0.4068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1673 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4621 1.2205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1673 1.6274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1673 2.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.4621 2.8481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7839 2.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7839 1.6274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0787 2.8481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3734 3.2549 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.0787 3.6619 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-2.3734 2.4412 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.9467 -0.4340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7605 -0.4340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1673 0.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7605 0.9764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9467 0.9764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5398 0.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7261 0.2712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1673 1.6817 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
4 6 1 0
2 7 1 0
7 6 1 0
7 8 2 0
8 9 1 0
10 9 2 0
6 11 2 0
11 10 1 0
8 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
22 21 1 0
18 23 1 0
23 22 2 0
24 23 1 0
16 25 1 0
25 24 2 0
25 26 1 0
26 27 1 0
22 28 1 0
28 29 1 0
29 30 1 6
29 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 35 1 0
31 36 1 0
36 35 2 0
35 37 1 0
37 38 1 0
37 39 1 0
37 40 1 0
3 41 1 0
41 42 1 0
42 43 1 0
43 44 1 0
45 44 1 0
41 46 1 0
46 45 1 0
46 47 2 0
44 48 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 662.63Molecular Weight (Monoisotopic): 662.2101AlogP: 4.72#Rotatable Bonds: 10Polar Surface Area: 151.85Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.59CX Basic pKa: 5.84CX LogP: 4.16CX LogD: 4.16Aromatic Rings: 4Heavy Atoms: 48QED Weighted: 0.16Np Likeness Score: -0.94
References 1. Bian Y, Alem D, Beato F, Hogenson TL, Yang X, Jiang K, Cai J, Ma WW, Fernandez-Zapico M, Tan AC, Lawrence NJ, Fleming JB, Yuan Y, Xie H.. (2022) Development of SOS1 Inhibitor-Based Degraders to Target KRAS -Mutant Colorectal Cancer., 65 (24.0): [PMID:36459180 ] [10.1021/acs.jmedchem.2c01300 ]